Skip to main content

T Cell Lymphoma clinical trials at UCSF

7 in progress, 4 open to eligible people

T cell lymphoma is a cancer of the immune system cells. UCSF is studying SGN-35C in patients with advanced cancers to find safer treatments. Another trial involves chemoimmunotherapy and stem cell transplants for NK T-cell leukemia. UCSF is also evaluating the combination of Belinostat or Pralatrexate with CHOP for PTCL.

Showing trials for

Our lead scientists for T Cell Lymphoma research studies include .

Last updated: